Literature DB >> 9399844

BTKbase, mutation database for X-linked agammaglobulinemia (XLA).

M Vihinen1, O Brandau, L J Brandén, S P Kwan, I Lappalainen, T Lester, J G Noordzij, H D Ochs, J Ollila, S M Pienaar, P Riikonen, B K Saha, C I Smith.   

Abstract

X-linked agammaglobulinemia (XLA) is an immunodeficiency caused by mutations in the gene coding for Bruton's agammaglobulinemia tyrosine kinase (BTK). A database (BTKbase) of BTK mutations has been compiled and the recent update lists 463 mutation entries from 406 unrelated families showing 303 unique molecular events. In addition to mutations, the database also lists variants or polymorphisms. Each patient is given a unique patient identity number (PIN). Information is included regarding the phenotype including symptoms. Mutations in all the five domains of BTK have been noticed to cause the disease, the most common event being missense mutations. The mutations appear almost uniformly throughout the molecule and frequently affect CpG sites that code for arginine residues. The putative structural implications of all the missense mutations are given in the database. The improved version of the registry having a number of new features is available at http://www. helsinki.fi/science/signal/btkbase.html

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9399844      PMCID: PMC147244          DOI: 10.1093/nar/26.1.242

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  46 in total

1.  Immunodeficiency mutation databases--a new research tool.

Authors:  C I Smith; M Vihinen
Journal:  Immunol Today       Date:  1996-11

2.  Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.

Authors:  R A Brooimans; A J van den Berg; G T Rijkers; L A Sanders; J K van Amstel; M G Tilanus; M J Grubben; B J Zegers
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

3.  Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.

Authors:  M Hyvönen; M Saraste
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

4.  A novel mutation (Cys145-->Stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male.

Authors:  S J Kornfeld; R N Haire; S J Strong; H Tang; S S Sung; S M Fu; G W Litman
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

Review 5.  X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.

Authors:  P T Mattsson; M Vihinen; C I Smith
Journal:  Bioessays       Date:  1996-10       Impact factor: 4.345

Review 6.  BTKbase: a database of XLA-causing mutations. International Study Group.

Authors:  M Vihinen; M D Cooper; G de Saint Basile; A Fischer; R A Good; R W Hendriks; C Kinnon; S P Kwan; G W Litman; L D Notarangelo
Journal:  Immunol Today       Date:  1995-10

Review 7.  Molecular and cellular aspects of X-linked agammaglobulinemia.

Authors:  P Sideras; C I Smith
Journal:  Adv Immunol       Date:  1995       Impact factor: 3.543

8.  Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA).

Authors:  H Jin; A D Webster; M Vihinen; P Sideras; I Vorechovsky; L Hammarstróm; E Bernatowska-Matuszkiewicz; C I Smith; M Bobrow; D Vetrie
Journal:  Hum Mol Genet       Date:  1995-04       Impact factor: 6.150

9.  Sequence specificity in CpG mutation hotspots.

Authors:  J Ollila; I Lappalainen; M Vihinen
Journal:  FEBS Lett       Date:  1996-11-04       Impact factor: 4.124

10.  BTKbase, mutation database for X-linked agammaglobulinemia (XLA).

Authors:  M Vihinen; T Iwata; C Kinnon; S P Kwan; H D Ochs; I Vorechovský; C I Smith
Journal:  Nucleic Acids Res       Date:  1996-01-01       Impact factor: 16.971

View more
  17 in total

Review 1.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype.

Authors:  H B Gaspar; M Ferrando; I Caragol; M Hernandez; J M Bertran; X De Gracia; T Lester; C Kinnon; E Ashton; T Espanol
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 3.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

4.  KinMutBase, a database of human disease-causing protein kinase mutations.

Authors:  K A Stenberg; P T Riikonen; M Vihinen
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

5.  Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.

Authors:  G M Dingjan; A Maas; M C Nawijn; L Smit; J S Voerman; F Grosveld; R W Hendriks
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

Review 6.  X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase.

Authors:  C I Smith; C M Bäckesjö; A Berglöf; L J Brandén; T Islam; P T Mattsson; A J Mohamed; S Müller; B Nore; M Vihinen
Journal:  Springer Semin Immunopathol       Date:  1998

7.  XLA patients with BTK splice-site mutations produce low levels of wild-type BTK transcripts.

Authors:  Jeroen G Noordzij; Sandra de Bruin-Versteeg; Nico G Hartwig; Corry M R Weemaes; Egbert J A Gerritsen; Eva Bernatowska; Stefaan van Lierde; Ronald de Groot; Jacques J M van Dongen
Journal:  J Clin Immunol       Date:  2002-09       Impact factor: 8.317

8.  Primary immunodeficiency diseases in Norway.

Authors:  A Stray-Pedersen; T G Abrahamsen; S S Frøland
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

9.  Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia.

Authors:  Cornelia Brunner; Hans Wolfgang Kreth; Hans D Ochs; Volker Schuster
Journal:  J Clin Immunol       Date:  2002-07       Impact factor: 8.317

Review 10.  X-linked immunodeficiencies.

Authors:  Hans D Ochs; Luigi D Notarangelo
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.